Introduction
Epilepsy is one of the most widespread neurological disorders in the world population and current pharmacological therapies remain insufficient to prevent epileptic seizures completely. The common features of all types of epilepsy are the synchronized and uncontrolled discharges of nerve cell assemblies. During epileptic seizures, the physiological balance between excitation and inhibition is altered towards the excitation.
The reason for the pathologically synchronized discharges of the neuron is not exactly known yet. The hypothesis of strengthened interconnections between neurons through electrical synapses, as a possible mechanism underlying neuronal Seizure (2007) Summary Epilepsy is an important problem in neurological disorders. The common features of all types of epilepsy are the synchronized and uncontrolled discharges of nerve cell assemblies. Recent studies claimed that gap junctions have a critical role in epileptic neuronal events. The aim of present study is to investigate the effects of connexin36 (Cx36) channel blocker quinine on penicillin-induced experimental epilepsy. For this purpose, 4 months old male Wistar rats were used in the present study. Permanent screw electrodes allowing EEG monitoring from conscious animals and permanent cannula providing the administration of the substances to the brain ventricle were placed into the cranium of rats under general anesthesia. At the end of the postoperative recovery period, epileptiform activity was generated by injecting 300 IU crystallized penicillin through the ventricular cannula. When the epileptiform activity, monitored from a digital recording system, reached maximal frequency and amplitude, quinine (200, 400 or 1000 nmol) was administered similar to penicillin. Effects of quinine on epileptiform activity were assessed by both electrophysiological and behavioral analysis. Quinine suppressed epileptiform activity by decreasing the amplitude and frequency of epileptiform spikes and by attenuating the epileptiform behavior. The outcomes of this study suggest that the blockade of Cx36 channels may contribute to the amelioration of epileptic activity. # 2006 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved. synchronization and epileptogenesis, was introduced about 20 years ago. 1 It has been recently proposed that neuronal gap junctions can represent a potential target for anticonvulsant therapy. The blockade of gap junction communication has been shown to reduce seizures in different epilepsy models, both in vitro [2] [3] [4] and in vivo 5,6 epilepsy models. Quinine, known to be antimalarial drug, has the ability to block Cx36 and Cx50 junctional currents in a reversible and concentration-dependent manner.
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Cx36 is the principal neuronal connexin in the adult brain, [8] [9] [10] [11] whereas Cx50 is expressed in the lens. 12 Studies have shown that Cx36 is expressed in gaminobutyric acid (GABA)ergic interneurons in several brain regions 13 and analysis of Cx36 knock-out mice have confirmed its role in interneuronal coupling. [14] [15] [16] In old papers, it has been reported that quinine treatment could be used in children against epilepsy. 17, 18 Recent studies also demonstrate that quinine has anticonvulsive effects in different epilepsy models. [19] [20] [21] The effects of quinine have been described in the 4-aminopyridine-induced in vivo epilepsy model, 21 but there is no other in vivo study regarding the effects of quinine on experimental epilepsy models. Penicillin may induce seizures in susceptible patients and it is structurally similar to GABA antagonist bicuculline. In the present study, we aimed to investigate whether quinine has anticonvulsant effects on penicillin-induced epileptiform activity in conscious rats by using behavioral and electrophysiological recording methods.
Materials and methods

Animals
Four-month-old male Wistar rats weighing 220 AE 30 g were used. Rats were kept in heat-regulated rooms, on a 12-h:12-h day/night cycle, and given as much food and water as needed. All experimental procedures were carried out according to the guidelines of European Community Council for experimental animal care.
Operation
The animals were anesthetized with ketamine hydrochloride (100 mg/kg, i.p.) and placed in a stereotaxic apparatus (David Kopf, MI). After midline incision, two stainless steel screw electrodes (1 mm diameter) were placed over the left frontal and parietal cortex. The reference electrode was placed at the center of the forehead, and all electrodes were attached to a connecting socket. A guide cannula (26-gauge) was implanted stereotaxically into the right lateral cerebral ventricle. The coordinates for cannula were: 0.6 mm posterior to Bregma, 2.0 mm lateral to the midline and 4.2 mm below the surface of the skull. 22 Then the electrodes and guide cannula were fixed using cold dental acrylic. Housed individually animals were allowed at least a week to recover from surgery. For the intracerebroventricular (i.c.v.) administration of drugs, animals were gently hand-restrained and drug infusions were made using injector cannula connected by a polyethylene tube to a 10 ml Hamilton (Type 701N) syringe (infusion rate 1 ml/min).
Experimental design
One week after the surgical procedure, rats were transferred to the observation cage. Fully conscious animals were connected to a computerized EEG recording system (PowerLab/4SP, AD Instruments) by an isolated flexible cable. After the rats habituated to the experimental and recording conditions, the baseline EEG activity was recorded for 30 min. Subsequently, penicillin G potassium (300 IU, in 3 ml) was injected into brain ventricle. Behavioral changes were noted and EEG was recorded for an additional 3 h. In order to investigate the effects of penicillin, recording continued until the end of epileptic activity in only penicillin group rats. It was found that epileptiform activity reached maximum frequency (182 AE 35 min À1 ) and amplitude (918 AE 96 mV) within 45 min and this maximum effect continued for 114 AE 12 min (n = 7). Therefore, in order to investigate the effects of quinine on epileptiform activity, the 114-min period in which penicillin had maximum effect was used.
Epileptic behaviors were scored according to a modified version of scale used by Patel et al. 23 : no response, 0; twitching of face and ear, fictive scratching, 1; myoclonic twitching and tremor, 2; bilateral forelimb clonus, 3; tonic-clonic seizure, 4; tonic-clonic seizure without postural control, 5.
Rats were divided into four groups: control (n = 7), quinine (n = 15), penicillin (n = 7) and penicillin + quinine (n = 21). Rats in the control group received only vehicle solution (i.c.v.) while animals in treatment groups received various doses (200, 400 and 1000 nmol, i.c.v.) of quinine after 1 h penicillin injection. In order to find out whether quinine changes baseline EEG activity, rats in quinine group were given quinine alone (200, 400 and 1000 nmol, i.c.v.). Quinine was dissolved in 5% dimethylsulfoxide (DMSO) solution. In this study, the drugs were administered to the brain ventricle only once in 3 ml volume.
At the end of the experiments, the position of the cannula was visually confirmed by 2% methylene blue infusion through the i.c.v. cannula after the animals were given a lethal dose of anesthetic.
Statistical analysis
Electrophysiological data were analyzed using Chart program (Version 5.2). Spike frequency and amplitude value were expressed as a percentage of control rates. Data obtained from recordings during the 5-min period prior to drug injections were assumed as control data of spike frequency and amplitude values. After the injections of the drugs, data were calculated in 5-min periods during 2 h. Then these data were compared to control data.
All statistical procedures were performed using SPSS (12.0) statistical software package. Values are expressed as means AE S.E.M. The effects of the drugs on spike frequency and amplitude were statistically evaluated by paired t-test, and analysis of variance (ANOVA) was used for differences between groups. Behavioral scores were analyzed by Wilcoxon matched-pairs signed-ranks test, and the Mann-Whitney U-test was used to determine whether there were differences between doses.
Drugs
Penicillin, quinine, ketamine hydrochloride and DMSO were purchased from Sigma Chemical Co. (St. Louis, MO, USA).
Results
Intracerebroventricular injection of 200 nmol (n = 5), 400 nmol (n = 5) and 1000 nmol (n = 5) quinine did not cause any change of the frequency or amplitude of EEG activity in respect to control baseline in non-penicillin injected animals (Fig. 1A) .
Penicillin induced an epileptiform EEG activity characterized by biphasic (positive and negative) spikes and spike-wave complexes. Appearance of epileptic discharges started 50 AE 14 s after i.c.v. crystallized penicillin (300 IU, 3 ml) administration (n = 7) (Fig. 1B) . Spike frequency and amplitude of epileptiform activity reached the maximum level at 36 AE 9 min, began to decline at 150 AE 18 min and disappeared at 227 AE 23 min. It was also observed that animals had behavioral tonic-clonic seizure 26 AE 7 min after penicillin administration.
The mean spike frequency was 182 AE 35 min À1 and the mean spike amplitude was 918 AE 96 mV before the quinine injection (n = 21). In penicillin + quinine group, spike frequencies were significantly decreased 17 AE 5, 12 AE 3 and 7 AE 4 min after injection of 200 nmol (n = 7), 400 nmol (n = 7) and 1000 nmol (n = 7) doses of quinine, respectively ( p < 0.05, Fig. 2 ). Spike amplitudes were also significantly reduced by 200, 400 and 1000 nmol quinine administration after 21 AE 6, 11 AE 4 and 5 AE 3 min, respectively ( p < 0.05, Fig. 3 ). Vehicle solution did affect neither frequency nor amplitude of epileptiform discharges induced by penicillin ( p > 0.05, Fig. 1C) .
It was found that administration of 200 nmol quinine decreased spike frequency to 77 AE 8% within 30 min ( p < 0.05, Fig. 2 ). The average amplitude of epileptiform discharges in the presence of 200 nmol quinine also decreased to 781 AE 73 mV ( p < 0.05, Fig. 1D ). At the 60 min of recording the spike frequency and amplitude were still 63 AE 12% and 83 AE 4%, respectively, below the control values (Figs. 2 and 3) .
Administration of 400 nmol quinine reduced the mean of spike amplitude from 918 AE 96 to 698 AE 51 mV within 30 min ( p < 0.05). The mean spike frequency was also 44 AE 14% less than control values at 30 min of recording ( p < 0.01, Figs. 1E and 2).
When 1000 nmol quinine was applied to the brain ventricle, epileptic discharges were more significantly decreased. The mean spike frequency was 59 AE 13% less than control values at 30 min after quinine application ( p < 0.001, Fig. 2 ). Simultaneously, the mean spike amplitude decreased to 562 AE 43 mV ( p < 0.01, Fig. 1F ).
Two hundred and 400 nmol doses of quinine caused significant decreases in epileptic behavioral score at 26 AE 5 and 14 AE 3 min, respectively, whereas 1000 nmol dose of quinine generated this effect at 9 AE 4 min ( p < 0.05, Table 1 ).
There were no statistically differences in spike frequency and amplitude between 200 and 400 nmol doses of quinine-treated rats ( p > 0.05). However, 1000 nmol quinine was more effective than the other two doses ( p < 0.05).
Discussion
In the present study, we examined the anticonvulsant properties of quinine, a selective pharmacologic blocker of Cx36, in penicillin-induced epileptic activity. This is the first study that demonstrates the effects of quinine on penicillin-induced generalized epileptiform activity. According to our findings, quinine significantly decreased epileptic activity in dose-dependent manner, and this effect was Growing evidence indicates that, besides the chemical synapses, direct coupling via gap junction channels provides a second major pathway, contributing to normal and abnormal physiological rhythms in developing and adult brain. [24] [25] [26] In a study on suprachiasmatic nucleus neurons, GABA has been reported to reduce gap junction mediated communications between these neurons. Researchers proposed that this effect of GABA was exerted via GABA A receptors and the mentioned effect was probably due to notably increased amounts of Cl À entrance into the cell altering the electrical properties of the membranes. 27 Because of penicillin's similar structure to GABA antagonist bicuculline, in the present study, epilepsy was produced by crystallized penicillin administration into the brain ventricle.
Penicillin model of experimental epilepsy was utilized by various researchers; nevertheless, most of these experiments have been performed under urethane anesthesia. 28, 29 It was reported that rapid waves disappeared 30 and slow waves began to dominate the brain waves in urethane-anesthetized rats. 31 Therefore, the present study was performed on fully conscious rats.
Ideal antiepileptic drug should correct the aberrant pathophysiology of epileptogenesis without interfering with physiological neurotransmission. 32 According to our findings, quinine did not alter baseline EEG activity. In the previous in vitro studies, it has been demonstrated that below a critical concentrations threshold, quinine does not influence basic electrophysiologic parameters and neuronal excitability. 20, 33 Gajda et al. reported that cortical administered quinine (20-40 mM) suppressed the seizure activity induced by 4-aminopyridine within 5-6 min. 21 In the present study, intracerebroventricular administration of quinine decreased epileptic activity within 7 min and our findings are consistent with results of this study.
It is known that convulsant substances increase transmission in electrical synapses in invertebrates. 34 The first data regarding direct linking of gap junctions with epilepsy was reported by Vaquero et al., who showed, in a morphological analysis, an increase in astrocytic gap junctions in an experimental model of epilepsy in cats. 35 Aronica et al. demonstrated that mRNAs of Cx36 known to be major neuronal connexin increased in human epileptic tissues. 36 Cx36, the major neuronal Cx, is present predominantly in GABAergic interneurons. 13, 14 In mice lacking Cx36, the gamma rhythms are desynchronized both in the cortex and in the hippocampus. 14, 15 Furthermore, a synchronizing role for electrical coupling in the spindle frequency ($10 Hz) has been described in the cat reticular neurons in vivo, 37 and it has been suggested that, because of the low-pass properties of gap junctions, 16 they can transmit spikes that can activate neighboring cells and thus contribute to the propagation and synchronization at low frequencies. 16 Spontaneous field inhibitory postsynaptic potentials (IPSPs) and GABAergic ictal-like events reflect the activity of a gap junction-coupled network of interneurons. These epileptic activities were completely and reversibly blocked by both quinine and as well as its optical isomer quinidine. 19 Gajda et al. also demonstrated antiepileptic effects of quinine in 4-aminopyridine induced in vivo seizure activity. 21 These findings are supported by the results of the present study that the uncoupling of Cx36 channels significantly decreased epileptic activity.
It has been shown that octanol, a non-specific gap junction blocker, suppresses 4-aminopyridine-and penicillin-induced seizure activity. 21, 38 Similarly, the antiepileptic effect of halothane, another non-specific gap junction blocker, has been reported in penicillin model epilepsy. 39 Recently, it has been demonstrated that L-arginine has regulated gap junctional intercellular coupling via nitric oxide. 40 There are also some studies concerning the antiepileptic effects of nitric oxide donors. 29, 41, 42 These reports are consistent with our results.
In conclusion, the presented results in our study demonstrate that quinine significantly decreased spike frequencies, spike amplitudes and epileptic behavioral score in a dose-dependent manner in penicillin model epilepsy. Quinine may have decreased the epileptiform activity via preventing gap junction mediated communication between neurons. Using of the specific gap junction blockers in the treatment of epilepsy may contribute to prevent the propagation and synchronization of the epileptiform activity. Future experiments are needed in order to characterize whether or not the blockade of selective connexins has a similar anticonvulsant activity in other animal models.
